328 filings
SC 13G
Avidity Partners Management LP
27 Mar 24
Jasper Therapeutics / Avidity Partners Management ownership change
4:26pm
4
JSPR
Jasper Therapeutics Inc
12 Mar 24
Jasper Therapeutics / Jeetinder Singh Mahal ownership change
9:33pm
144
Jeetinder Singh Mahal
12 Mar 24
Notice of proposed sale of securities
8:50pm
144
JSPR
Jasper Therapeutics Inc
6 Mar 24
Notice of proposed sale of securities
5:49pm
S-8
JSPR
Jasper Therapeutics Inc
5 Mar 24
Registration of securities for employees
4:52pm
10-K
2023 FY
JSPR
Jasper Therapeutics Inc
Annual report
5 Mar 24
4:02pm
8-K
JSPR
Jasper Therapeutics Inc
4 Mar 24
Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments
7:40am
4
JSPR
Jasper Therapeutics Inc
20 Feb 24
Jasper Therapeutics / RON MARTELL ownership change
7:33pm
4
JSPR
Jasper Therapeutics Inc
20 Feb 24
Jasper Therapeutics / Jeetinder Singh Mahal ownership change
7:31pm
4
JSPR
Jasper Therapeutics Inc
20 Feb 24
Jasper Therapeutics / HERB CROSS ownership change
7:27pm
4
Tucker Edwin Jonathan
20 Feb 24
Jasper Therapeutics / Edwin Jonathan Tucker ownership change
7:22pm
SC 13G/A
JSPR
Jasper Therapeutics Inc
14 Feb 24
Jasper Therapeutics / CITADEL ADVISORS ownership change
6:18pm
SC 13G/A
JSPR
Jasper Therapeutics Inc
14 Feb 24
Jasper Therapeutics / Qiming U.S. Healthcare Fund II ownership change
4:18pm
SC 13G/A
Biotechnology Value Fund L P
14 Feb 24
Jasper Therapeutics / BIOTECHNOLOGY VALUE FUND L P ownership change
9:41am
4
Carlyle Genesis UK LLC
12 Feb 24
Change in insider ownership
6:23pm
SC 13D/A
JSPR
Jasper Therapeutics Inc
12 Feb 24
Jasper Therapeutics / Carlyle ownership change
6:00pm
4
Avego Healthcare Capital Holdings, LLC
9 Feb 24
Jasper Therapeutics / BALAJI VENKATARAMAN ownership change
8:40pm
SC 13D/A
Velan Capital Investment Management LP
9 Feb 24
Jasper Therapeutics / Velan Capital Investment Management ownership change
8:36pm
424B5
JSPR
Jasper Therapeutics Inc
7 Feb 24
Prospectus supplement for primary offering
12:00am
8-K
JSPR
Jasper Therapeutics Inc
6 Feb 24
Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock
9:07am